Anil Chhabra

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension

Luke J. Laffin, David Rodman, James M. Luther et al. · JAMA · 2023 · 190 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension

Manish Saxena, Luke J. Laffin, Claudio Borghi et al. · JAMA · 2025 · 68 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Phase I Clinical Trial of MPC-6827 (Azixa), a Microtubule Destabilizing Agent, in Patients with Advanced Cancer

Apostolia M. Tsimberidou, Wallace Akerley, Matthias C. Schabel et al. · Molecular Cancer Therapeutics · 2010 · 51 citations

Medicine, Oncology, Pharmacology +16

Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme

John M. Lasala, David A. Cox, S. R. Lewis et al. · EuroIntervention · 2009 · 35 citations

Medicine, Cardiology, Internal Medicine +17